News
2d
MedPage Today on MSNPulmonary Rehabilitation for COPD Pushes ForwardHome-based pulmonary rehabilitation has been slowly gaining momentum for chronic obstructive pulmonary disease (COPD), but ...
2d
MedPage Today on MSNEasing Airway Assaults in COPDFor COPD patients, the adage holds true: "the first way to get out of a hole is to quit digging one," said Christopher Mosher ...
2don MSN
Walking is a fundamental activity for maintaining health. While numerous studies have assessed how much people with chronic ...
Yet thanks to a new hospital-based educational and advocacy initiative for COPD patients, Croswell has been managing well at ...
Topline results were announced from two phase 3 trials evaluating itepekimab in former smokers with inadequately controlled COPD.
5d
Pharmaceutical Technology on MSNSanofi and Regeneron report results from two Phase III trials of COPD treatmentSanofi and Regeneron have reported that the Phase III AERIFY-1 trial of the fully human monoclonal antibody itepekimab.
Chronic obstructive pulmonary disease (COPD) affects millions of Americans, with new data from the National Center for Health Statistics showing the condition becomes increasingly common as people age ...
(Reuters) -Regeneron shares fell nearly 18% on Friday after its experimental drug for patients with a type of lung condition ...
People who lost weight in midlife were less likely to experience heart attacks, strokes, cancer, asthma or chronic ...
Long-term health care utilization is greater among patients with COPD who have tested positive for COVID-19 and are unvaccinated.
Sanofi’s plans to submit itepekimab to regulators for approval this year have been thrown into doubt after the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results